权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Modeling HIV/AIDS Associated Neurological Disorders with Human Pluripotent Cells

用人类多能细胞模拟艾滋病毒/艾滋病相关的神经系统疾病

基本信息

批准号：
9635762
负责人：
TARIQ M RANA
金额：
$ 77.5万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-03-01 至 2022-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9635762
关键词：
13 year old AIDS/HIV problem Acquired Immunodeficiency Syndrome Aging Agitation Anti-Retroviral Agents Anxiety Area Attention Biological Models Biology Blood - brain barrier anatomy Brain Brain Injuries Cells Centers for Disease Control and Prevention (U.S.)Cerebrum Chronic Data Defect Development Disease model Dopamine Drug abuse Epigenetic Process Event Exhibits HIV HIV Infections HIV-associated neurocognitive disorder Health Hepatitis C co-infection High Prevalence Highly Active Antiretroviral Therapy Human Hypertension Individual Lead Maintenance Memory Methamphetamine Microglia Modeling Molecular Nerve Degeneration Neuraxis Organoids Pathogenesis Patients Penetration Pharmaceutical Preparations Physiological Pluripotent Stem Cells Psychotic Disorders Societies Substance abuse problem Symptoms Synapses Toxic effect United States Untranslated RNA Work aging brain antiretroviral therapy base dopamine transporter drug testing executive function human model in vivo interdisciplinary approach macrophage methamphetamine abuse methamphetamine user nervous system disorder neuroinflammation novel psychostimulant public health relevance regenerative serotonin transporter socioeconomics success

项目摘要

DESCRIPTION: Approximately 40 million people worldwide are infected with human immunodeficiency virus. According to the CDC estimates, 1,144,500 people aged 13 years and older are living with HIV infection in the USA, with ~180,900 (15.8%) others infected but undiagnosed. The advent of combination antiretroviral therapy (cART; also known as highly active antiretroviral therapies, HAART) has transformed AIDS from a fatal illness into a chronic and manageable condition. Despite the success of cART, high prevalence of HIV-associated neurocognitive disorders (HAND) poses a major challenge for the society. It is estimated that 30-50% of individuals with HIV suffer from HAND, and approximately 350,000-575,000 cases in the United States alone HAND persist after cART likely due to the HIV infected microglia and macrophage reservoirs in the central nervous system and variable penetration of anti-retroviral drugs across the blood brain barrier. Additional factors such as CNS toxicity of cART, the aging of the brain, hepatitis C co-infection and substance abuse are known to exacerbate the symptoms of HAND. Methamphetamine (METH) is a psychostimulant drug that is chronically abused by an estimated 25 million people in the world. METH users exhibit an array of health complications ranging from agitation, anxiety, hypertension, psychosis and deficits in memory, attention and executive functions. Moreover, evidence suggests that METH can lead to neuroinflammation and neurodegeneration including loss of dopamine transporters, loss of serotonin transporters, increased dopamine levels, breakdown of the blood brain barrier. HAND and METH drug abuse are major health problems with huge socioeconomical burdens on society. Molecular mechanisms of HAND and METH are not well understood, partly due to the lack of physiologically relevant human model systems. Proposed work will develop pluripotent stem cell based cerebral organoid models and employ multidisciplinary approaches to investigate novel regulatory non-coding RNAs and epigenetics mechanisms, a nascent area in biology, of brain injury caused by HAND/METH. Because of their ability to self-organize and recapitulate many regenerative events seen in vivo, organoids present a human relevant, easily accessible, scalable model for disease pathogenesis and drug testing. Since we are able to control the microenvironment of organoid formation and maintenance, brain functions under various human conditions related to development, aging, and cART treatments can be studied. Results will be correlated with patients' data and drugs will be screened to rescue synaptic defects caused by HIV and METH.

描述：全球约有4000万人感染了人类免疫缺陷病毒。根据美国疾病控制与预防中心的估计，在美国，13岁及以上的人中有1,144,500人感染了艾滋病毒，还有大约180,900人(15.8%)感染了艾滋病毒，但没有得到诊断。联合抗逆转录病毒疗法(CART；也称为高效抗逆转录病毒疗法，HAART)的出现将艾滋病从一种致命的疾病转变为一种慢性和可控制的疾病。尽管CART取得了成功，但艾滋病毒相关神经认知障碍(HAND)的高患病率对社会构成了重大挑战。据估计，30-50%的HIV感染者患有手部疾病，仅在美国就有大约350,000-575,000例手部患者在手部存活，这可能是由于HIV感染的小胶质细胞和巨噬细胞储存库位于中枢神经系统，以及抗逆转录病毒药物对血脑屏障的渗透程度不同。已知的其他因素，如CART的中枢神经系统毒性、大脑老化、丙型肝炎合并感染和药物滥用，都会加剧手部症状。甲基苯丙胺(冰毒)是一种精神刺激药物，据估计全世界有2500万人长期滥用。冰毒使用者表现出一系列的健康并发症，从激动、焦虑、高血压、精神病以及记忆、注意力和执行功能的缺陷。此外，有证据表明，冰毒会导致神经炎症和神经变性，包括失去多巴胺转运体，失去5-羟色胺转运体，增加多巴胺水平，破坏血脑屏障。手和冰毒滥用是主要的健康问题，给社会带来了巨大的社会经济负担。手和冰毒的分子机制还不是很清楚，部分原因是缺乏与生理相关的人体模型系统。拟议的工作将开发基于多潜能干细胞的脑器官模型，并使用多学科方法来研究由手/冰毒引起的脑损伤的新的调控非编码RNA和表观遗传学机制，这是生物学中的一个新领域。由于有机化合物能够自组织和概括体内看到的许多再生事件，它为疾病发病机制和药物测试提供了一种与人类相关的、容易获得的、可扩展的模型。由于我们能够控制有机体形成和维持的微环境，因此可以研究与发育、衰老和CART治疗相关的各种人类条件下的大脑功能。结果将与患者的数据相关联，并将筛选药物以挽救艾滋病毒和冰毒造成的突触缺陷。